ClinicalTrials.Veeva

Menu

Shared Healthcare Actions and Reflections Electronic Systems in Survivorship

Wake Forest University (WFU) logo

Wake Forest University (WFU)

Status

Completed

Conditions

Hematopoietic and Lymphoid Cell Neoplasm
Survivorship
Cancer
Malignant Solid Neoplasm

Treatments

Behavioral: SHARE-S Implementation Program

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04337203
WFBCCC 99420 (Other Identifier)
IRB00064683
1P50CA244693-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The primary purpose of this study is conduct a pilot study testing the study protocols, implementation program, and mixed-methods data collection.

Full description

Primary Objectives:

• To evaluate how successfully SHARE-S can be implemented into clinical care as characterized by rates of enrollment. Investigators hypothesize >30% of patients e-referred to SHARE-S will enroll.

Secondary Objectives:

  • To assess additional implementation outcomes that evaluate preliminary implementation success (i.e., further assessment of adoption, acceptability, appropriateness, further assessment of feasibility, and fidelity).
  • To describe service outcome variability to inform future studies. Investigators will assess service outcomes relevant to Commission on Cancer requirements by reporting annual estimates for: (1) the estimated number of patients impacted by SHARE-S; (2) the cancer sites impacted by SHARE-S; and the (3) resources/processes utilized to enhance each of the chosen services if barriers were encountered. We will also assess safety and perceived patient-centeredness of care.
  • To describe patient health outcome variability to inform future studies (i.e., social role, physical functioning, anxiety, depression, fatigue, sleep disturbance, pain, cancer-specific quality of life, health behaviors, patient autonomy, self-efficacy for managing cancer, engagement with the survivorship care plan document, and satisfaction with care).
  • To evaluate the Implementation Program we will assess key milestones and processes for this pilot study of the Implementation Stage measured at the clinic level.
  • To qualitatively assess implementation barriers and facilitators using semi-structured interviews that will be audio-recorded.
  • To examine how study results vary by cancer type.

Enrollment

40 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Adults ≥18 years of age
  • Documented or planned cancer survivorship visit
  • Have a texting enabled telephone
  • Cognitively able to complete study procedures as judged by the study team
  • Able to understand, read and write English

Children under the age of 18 with cancer will be excluded due to the potentially different self-management support intervention needs of this population that will likely include parental involvement. Results from this research may inform future studies in children with cancer under 18 who should be researched separately.

Exclusion Criteria

  • Declined participation in the study

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

SHARE-S
Experimental group
Description:
Three components consisting of electronic referral, health coaching and tailored text/email messages for patients that have been referred to the cancer survivorship clinic.
Treatment:
Behavioral: SHARE-S Implementation Program

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems